Clinical trial
Analysis of the Expression of a Specific Set of Genes and Tumor Antigens in Patients With Non-small Cell Lung Cancer or Melanoma
NCT00685750 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of the Expression of a Specific Set of Genes and Tumor Antigens in Patients With Non-small Cell Lung Cancer or Melanoma
- Lead sponsor
- GlaxoSmithKline
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- April 28, 2008
- Completion date
- December 17, 2013
- Enrollment
- 88 (actual)
- Sites
- 34
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, non-small cell